/Companies

CellType

YC W26

New York City, US · Founded 2025 · 5 employees · Hiring · 20 known investors

Find your way into CellType

Sign up to see every warm intro you have to CellType

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the CellType team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

CellType uses AI agents and biological models to automate drug discovery, having identified a novel cancer treatment signal and partnering with major pharmaceutical companies.

Also known as Contextual Bio

BiotechHealthtechUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (W26)

CellType was founded in 2025 by David van Dijk and Ivan Vrkic.

DVDavid van Dijk
David van DijkCo-Founder & CEODavid van Dijk holds a position as professor at Yale and has contributed to biological foundation models research. He is co-founder and CEO of CellType.
IVIvan Vrkic
Ivan VrkicCo-FounderHe studied machine learning at Yale and EPFL, contributed to Cell2Sentence research published at ICML, and previously led foundation model training at a biotech startup and developed software for CERN's Large Hadron Collider.

Investors · 20

ACVC Partnerslisted by ACVC PartnersSilicon Valley

How we know: Y Combinator's founder network · Not right? Tell us

0 ADreported

How we know: Y Combinator's founder network · Not right? Tell us

Batch Venturesreported

How we know: Y Combinator's founder network · Not right? Tell us

ETA Capital PartnersreportedBoston

How we know: Y Combinator's founder network · Not right? Tell us

Exit Venturesreported

How we know: Y Combinator's founder network · Not right? Tell us

Founders FactoryreportedLondon · $150K – $200K

How we know: Y Combinator's founder network · Not right? Tell us

MA7 VenturesreportedAlmaty · $150K – $1M

How we know: Y Combinator's founder network · Not right? Tell us

OurCrowdreportedJerusalem

How we know: Y Combinator's founder network · Not right? Tell us

Perpetual VCreportedNew York

How we know: Y Combinator's founder network · Not right? Tell us

RobinhoodreportedMenlo Park

How we know: Y Combinator's founder network · Not right? Tell us

SAV (Scale Asia Ventures)reportedPalo Alto

How we know: Y Combinator's founder network · Not right? Tell us

SGH CapitalreportedParis

How we know: Y Combinator's founder network · Not right? Tell us

Tabula Rasa Venturesreported$50K – $1M

How we know: Y Combinator's founder network · Not right? Tell us

Trivest Family OfficesreportedCoral Gables

How we know: Y Combinator's founder network · Not right? Tell us

Unpopular VenturesreportedMiami · $100K – $500K

How we know: Y Combinator's founder network · Not right? Tell us

Related companies · 2

Companies working in the same space as CellType.

Legal entities · 1

corporate structure
CellType Inc.

In the news

Frequently asked questions

What does CellType do?
CellType uses AI agents and biological models to automate drug discovery, having identified a novel cancer treatment signal and partnering with major pharmaceutical companies.
Who founded CellType?
CellType was founded by David van Dijk, Ivan Vrkic in 2025.
Who are CellType's investors?
CellType's investors include ACVC Partners, Eight Capital, Pioneer, Y Combinator, ZAKA VC, 0 AD, Batch Ventures, ETA Capital Partners and 12 more.
Where is CellType headquartered?
CellType is headquartered in New York City, US.